Article

Multi-institutional Assessment of Pathologist scoring HER2 Immunohistochemistry

2022-07-05

Abstract excerpt

<title>Abstract</title> <p>The HercepTest was approved 20 + years ago as the companion diagnostic test for trastuzumab in HER2 amplified/overexpressing breast cancers. Subsequent HER2 immunohistochemistry (IHC) assays followed, including the now most common Ventana 4B5 assay. While this IHC assay has become the clinical standard, its reliability, reproducibility, and accuracy have largely been approved and accept...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6a5a437c-b6c3-5cd0-afbc-1f67ed9bd311
DOI: 10.21203/rs.3.rs-1763087/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-institutional Assessment of Pathologist scoring HER2 ImmunohistochemistryDOI 10.21203/rs.3.rs-1763087/v1Read

Impact of a machine learning-powered algorithm on pathologist HER2 IHC scoring in breast cancerSemantic proximity Read

A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.Semantic proximity Read

Artificial Intelligence Model’s assessment of intra-sample heterogeneity of HER2 IHC in breast cancer is related to interobserver and intraobserver agreement among pathologistsSemantic proximity Read

HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring study.Semantic proximity Read

Interobserver Reproducibility Study of Macroscopic Classification of Breast Cancer from Representative Cut surface of Resected Specimens and Hematoxylin–Eosin-Stained SlidesSemantic proximity Read

Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic StudiesSemantic proximity Read

Interlaboratory variability of HER2 fluorescence in situ hybridization testing in breast cancer: results of a multicenter proficiency-testing ring study in ChinaSemantic proximity Read

Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancerSemantic proximity Read

Computer-aided scoring of erb-b2 receptor tyrosine kinase 2 (HER2) gene amplification status in breast cancerSemantic proximity Read

Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing.Semantic proximity Read

High Concordance Between Two Companion Diagnostics TestsSemantic proximity Read

From Categorical to Continuous: A Symbiotic Human-AI Approach to HER2 Scoring in the Antibody-Drug Conjugates EraSemantic proximity Read